Skip to main content

Monoclonal Antibodies and Breast Cancer

Proceedings of the International Workshop on Monoclonal Antibodies and Breast Cancer San Francisco, California — November 8–9, 1984

  • Conference proceedings
  • © 1985

Overview

Part of the book series: Developments in Oncology (DION, volume 35)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (21 papers)

  1. Session I

  2. Session II

  3. Session III

Keywords

About this book

Breast cancer, being a disease with very high prevalence in the female population, has permanently attracted the attention of biologists, biochemists, pathologists, surgeons, and oncologists. In the U.S. alone approximately 120,000 new cases are diagnosed and 37,000 deaths a year are recorded as an outcome. Early diagnosis, clear cut prognosis and the hope of new therapeutic approaches has spurred the enthusiasm of researchers, who with the advent of newer methodologies, tried to employ it in different approaches to the breast cancer patient. In spite of the efforts devoted towards the creation of new approaches, reagents and procedures taking advantage of special characteristics of the breast tissue were slow to come. In general, most diagnostic and prognostic techniques were those shared and applied to other carcinomas. In the early seventies we discovered the first sets of antigens associated with breast epithelial tissue both in the mouse and the human. The recognition of such group of molecules, present in the milk fat globule membrane, gave impetus to several studies in these areas. These mammary cell surface antigens proved useful in several diagnostic approaches such as radioimaging, histochemical and serum assay procedures. However, the apparently inherent limitations of polyclonal antibodies reduced the impact of these novel approaches.

Editors and Affiliations

  • John Muir Cancer and Aging Research Insitute, Walnut Creek, USA

    Roberto L. Ceriani

Bibliographic Information

  • Book Title: Monoclonal Antibodies and Breast Cancer

  • Book Subtitle: Proceedings of the International Workshop on Monoclonal Antibodies and Breast Cancer San Francisco, California — November 8–9, 1984

  • Editors: Roberto L. Ceriani

  • Series Title: Developments in Oncology

  • DOI: https://doi.org/10.1007/978-1-4613-2617-5

  • Publisher: Springer New York, NY

  • eBook Packages: Springer Book Archive

  • Copyright Information: Martinus Nijhoff Publishing, Boston 1985

  • Hardcover ISBN: 978-0-89838-739-1Published: 31 July 1985

  • Softcover ISBN: 978-1-4612-9637-9Published: 04 January 2012

  • eBook ISBN: 978-1-4613-2617-5Published: 06 December 2012

  • Edition Number: 1

  • Number of Pages: XXII, 314

  • Topics: Oncology

  • Industry Sectors: Biotechnology, Health & Hospitals, Pharma

Publish with us